Literature DB >> 15160305

Plasma hepatocyte growth factor is increased in early-phase sepsis.

Kazuhiko Sekine1, Seitaro Fujishima, Naoki Aikawa.   

Abstract

To elucidate the involvement of hepatocyte growth factor (HGF) in systemic inflammatory response syndrome (SIRS) and sepsis, we investigated the plasma levels of HGF, as well as those of various proinflammatory and anti-inflammatory cytokines, in 50 patients who visited our emergency department (ED). The patients were divided into four groups, depending on the existence of SIRS and infection: group 1 (G1), no infection and no SIRS; group 2 (G2), infection and no SIRS; group 3 (G3), no infection and SIRS; and group 4 (G4), infection and SIRS (e.g., sepsis). We found that plasma HGF levels in G4 were significantly higher than those in the groups without infection (G1 and G3). However, the correlations between HGF and other cytokines were comparatively low compared with those between any other pairs of cytokines, suggesting independent regulation of HGF production in vivo. High plasma HGF was significantly correlated with the presence of infection and with serum total bilirubin (TB) level on multivariate logistic regression analysis. Considering HGF's known functions, we speculated that high plasma HGF levels may indicate the occurrence or necessity for tissue protection and regeneration after acute systemic insults in sepsis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160305     DOI: 10.1007/s10156-004-0301-y

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  11 in total

1.  Hepatotropic growth factors protect hepatocytes during inflammation by upregulation of antioxidative systems.

Authors:  Matthias Glanemann; Daniel Knobeloch; Sabrina Ehnert; Mihaela Culmes; Claudine Seeliger; Daniel Seehofer; Andreas K Nussler
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Gene expression profiling of long-term changes in rat liver following burn injury.

Authors:  Arul Jayaraman; Tim Maguire; Murali Vemula; Deukwoo W Kwon; Marina Vannucci; Francois Berthiaume; Martin L Yarmush
Journal:  J Surg Res       Date:  2007-08-28       Impact factor: 2.192

Review 3.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma.

Authors:  S Karabulut; F Tas; F Akyüz; A C Ormeci; M Serilmez; H O Soydinç; S Vatansever; V Yasasever
Journal:  Tumour Biol       Date:  2013-10-20

5.  Sphingolipids Signaling in Lamellipodia Formation and Enhancement of Endothelial Barrier Function.

Authors:  Panfeng Fu; Mark Shaaya; Anantha Harijith; Jeffrey R Jacobson; Andrei Karginov; Viswanathan Natarajan
Journal:  Curr Top Membr       Date:  2018-09-27       Impact factor: 3.049

6.  Improvement of sepsis by hepatocyte growth factor, an anti-inflammatory regulator: emerging insights and therapeutic potential.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

7.  Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit.

Authors:  Beata Mickiewicz; Patrick Tam; Craig N Jenne; Caroline Leger; Josee Wong; Brent W Winston; Christopher Doig; Paul Kubes; Hans J Vogel
Journal:  Crit Care       Date:  2015-01-15       Impact factor: 9.097

8.  Gene Ontology Analysis for Drug Targets of the Whole Genome Transcriptome of Human Vascular Endothelial Cells in Response to Proinflammatory IL-1.

Authors:  Tom Skaria; Esther Bachli; Gabriele Schoedon
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

9.  Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.

Authors:  Jaume Sauleda; Aina Noguera; David Blanquer; Jaume Pons; Meritxell López; Cristina Villena; Alvar G N Agustí
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung.

Authors:  Carla Calvi; Megan Podowski; Armando Lopez-Mercado; Shana Metzger; Kaori Misono; Alla Malinina; Dustin Dikeman; Hataya Poonyagariyon; Leslie Ynalvez; Roshanak Derakhshandeh; Anne Le; Mark Merchant; Ralph Schwall; Enid R Neptune
Journal:  PLoS Genet       Date:  2013-02-14       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.